CARIS LIFE SCIENCES

Live / Registered — Registered (as of 04 Jun 2024)

What this means for you

Registered since 04 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97194537
Registration number
7404489
Mark type
Stylized text
Filed
29 Dec 2021
Published for opposition
12 Mar 2024
Registered
04 Jun 2024
Attorney of record
Anne Fleeson

Goods and services

  • Class 042 — Scientific and technological services: Medical research; medical and scientific research services in the fields of anatomic pathology, molecular profiling, blood-based diagnostics, oncology, genomics, and proteomics; pharmaceutical research and development; genetic and proteomic research studies of specimens; genetic and proteomic research studies of specimens, namely, cellular manipulation, light microscopic examination, immunohistochemistry flow cytometry, expression profiling, microarray analysis, genetic signatures, specific genetic targets, DNA/RNA isolation and western blot analysis, facilitating effective clinical trials, product development, and research using large amounts of biospecimens and associated research and patient data; providing temporary use of online, nondownloadable software for tracking laboratory information featuring customized biospecimens and coordinating and conducting follow-on studies to complement the clinical findings; medical and scientific research; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials; medical research laboratory services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; medical research laboratory services, namely, providing patient history reports based on analysis of RNA, DNA and protein to aid physicians in determining diagnosis, prognosis, and predicting or monitoring therapeutic response for cancer patients; providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumor profiling information and clinical outcomes within a collaborative, secured environment, all for treatment and diagnostic purposes

Owner

Prosecution history

  • 04 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 04 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
  • 19 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 19 Mar 2024 — PUBLISHED FOR OPPOSITION
  • 28 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 28 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 30 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 08 Jan 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
  • 19 May 2023 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
  • 19 May 2023 — LETTER OF SUSPENSION E-MAILED
  • 19 May 2023 — SUSPENSION LETTER WRITTEN
  • 13 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 13 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 13 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 06 Oct 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED

View this trademark record on Marksy